已选(0)清除
条数/页: 排序方式: |
| Rich people are boiling the planet 科技资讯 2023 收藏  |  浏览/下载:5/0  |  提交时间:2023/10/20 |
| Climate Change 2022: Mitigation of Climate Change 科技报告 , 2022 作者: Jim Skea JPEG(8Kb)  |  收藏  |  浏览/下载:138/33  |  提交时间:2022/04/06 |
| Hamburg Climate Futures Outlook Assessing the Plausibility of Deep Decarbonization by 2050 科技报告 , 2021 作者: [unavailable] Adobe PDF(6832Kb)  |  收藏  |  浏览/下载:15/0  |  提交时间:2021/11/24 |
| Progress in Adapting to Climate Change - 2021 Report to Parliament 科技报告 , 2021 作者: [unavailable] Adobe PDF(9065Kb)  |  收藏  |  浏览/下载:17/0  |  提交时间:2021/11/24 |
| At last, a malaria vaccine has passed important clinical trials 科技资讯 2021 收藏  |  浏览/下载:18/0  |  提交时间:2021/05/12 |
| New Zealand's Greenhouse Gas Inventory 1990-2019 科技报告 , 2021 作者: [unavailable] Adobe PDF(9763Kb)  |  收藏  |  浏览/下载:15/1  |  提交时间:2021/11/24 |
| Reflecting Sunlight Recommendations for Solar Geoengineering Research and Research Governance 科技报告 , 2021 作者: [unavailable] Adobe PDF(6091Kb)  |  收藏  |  浏览/下载:14/0  |  提交时间:2021/11/24 |
| Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination 期刊论文 Proceedings of the National Academy of Sciences of the United States of America, 2021, 卷号: 118, 期号: 28 作者: Tscherne A.; Hendrik Schwarz J.; Rohde C.; Kupke A.; Kalodimou G.; Limpinsel L.; Okba N.M.A.; Bošnjak B.; Sandrock I.; Odak I.; Halwe S.; Sauerhering L.; Brosinski K.; Liangliang N.; Duell E.; Jany S.; Freudenstein A.; Schmidt J.; Werner A.; Serra M.G.; Klüver M.; Guggemos W.; Seilmaier M.; Wendtner C.-M.; Förster R.; Haagmans B.L.; Becker S.; Sutter G.; Volz A. 收藏  |  浏览/下载:41/0  |  提交时间:2021/11/25 |
| Complete biosynthesis of the potential medicine icaritin by engineered Saccharomyces cerevisiae and Escherichia coli 期刊论文 Science Bulletin, 2021 作者: Wang P.; Li C.; Li X.; Huang W.; Wang Y.; Wang J.; Zhang Y.; Yang X.; Yan X.; Wang Y.; Zhou Z. 收藏  |  浏览/下载:22/0  |  提交时间:2021/09/01 |
| Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 15 作者: Ji L.; Song W.; Fang H.; Li W.; Geng J.; Wang Y.; Guo L.; Cai H.; Yang T.; Li H.; Yang G.; Li Q.; Liu K.; Li S.; Liu Y.; Shi F.; Li X.; Gao X.; Tian H.; Ji Q.; Su Q.; Zhou Z.; Wang W.; Zhou Z.; Li X.; Xu Y.; Ning Z.; Cao H.; Pan D.; Yao H.; Lu X.; Jia W. 收藏  |  浏览/下载:37/0  |  提交时间:2021/09/01 Carfloglitazar Chiglitazar Glycemic control Insulin resistance PPAR pan-agonist Type 2 diabetes |